Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion. | BMC Med Genomics | 2022 | 35197055 | PubTator, text mining | PubMed |
| A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans. | PLoS Biol | 2022 | 35192608 | PubTator, text mining | PubMed |
| RNA Analysis and Clinical Characterization of a Novel Splice Variant in the NSD1 Gene Causing Familial Sotos Syndrome. | Front Pediatr | 2022 | 35186810 | PubTator, text mining | PubMed |
| Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation. | PeerJ | 2022 | 35186455 | PubTator, text mining | PubMed |
| Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. | Am J Hematol | 2022 | 35180323 | PubTator, text mining | PubMed |
| DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells. | Int J Biol Sci | 2022 | 35173548 | PubTator, text mining | PubMed |
| Quantitative profiling of adaptation to cyclin E overproduction. | Life Sci Alliance | 2022 | 35173014 | PubTator, text mining | PubMed |
| The role of exosomal CDC6 in the hirudin-mediated suppression of the malignant phenotype of bladder cancer cells. | Gene | 2022 | 35150820 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| Cdc6 is sequentially regulated by PP2A-Cdc55, Cdc14, and Sic1 for origin licensing in S. cerevisiae. | Elife | 2022 | 35142288 | PubTator, text mining | PubMed |
| Construction of the miRNA-mRNA regulatory network and analysis of hub genes in oral squamous cell carcinoma. | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | 2022 | 35132271 | PubTator, text mining | PubMed |
| REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis. | Cell Death Dis | 2022 | 35115490 | PubTator, text mining | PubMed |
| Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines. | Emerg Microbes Infect | 2022 | 35109781 | PubTator, text mining | PubMed |
| PIF7 controls leaf cell proliferation through an AN3 substitution repression mechanism. | Proc Natl Acad Sci U S A | 2022 | 35086930 | PubTator, text mining | PubMed |
| The consequences of differential origin licensing dynamics in distinct chromatin environments. | Nucleic Acids Res | 2022 | 35079814 | PubTator, text mining | PubMed |
| Therapeutic efficacy of FASN inhibition in preclinical models of HCC. | Hepatology | 2022 | 35076948 | PubTator, text mining | PubMed |
| A natural product targets BRD4 to inhibit phase separation and gene transcription. | iScience | 2022 | 35072011 | PubTator, text mining | PubMed |
| Oncogene or Tumor Suppressor: The Coordinative Role of Lysine Methyltransferase SET7/9 in Cancer Development and the Related Mechanisms. | J Cancer | 2022 | 35069908 | PubTator, text mining | PubMed |
| CDK4/6 inhibitors induce replication stress to cause long-term cell cycle withdrawal. | EMBO J | 2022 | 35037284 | PubTator, text mining | PubMed |
| The Effect of High CDC6 Levels on Predicting Poor Prognosis in Colorectal Cancer. | Chemotherapy | 2022 | 35034031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=34